Sunil Abhyankar

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 645 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Corey Cutler, Stephanie J. Lee, Sally Arai et al. · Blood · 2021 · 327 citations · Full text

Life Sciences, Immunology, Surgery +9

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

Javier Bolaños‐Meade, Ran Reshef, Raphael Fraser et al. · The Lancet Haematology · 2019 · 281 citations

Medicine, Immunology, Pharmacotherapy +16

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation

Adriana Bastidas, Javier de la Serna, Mohamed El Idrissi et al. · JAMA · 2019 · 257 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Use of Partially Mismatched Related Donors Extends Access to Allogeneic Marrow Transplant

P. Jean Henslee‐Downey, Sunil Abhyankar, Rudolph S. Parrish et al. · Blood · 1997 · 214 citations · Full text

Medicine, Hematology, Immunology +11